EntreMed To Change Name To CASI Pharma - Quick Facts

(RTTNews) - EntreMed, Inc. (ENMD), a clinical-stage biopharmaceutical company developing therapeutics for the treatment of cancer and other diseases, said that at its annual meeting of stockholders held on June 12, stockholders voted in favor of changing the company's corporate name to CASI Pharmaceuticals, Inc.

The name change will occur on June 16, with the company's common stock trading on NASDAQ under the new symbol "CASI" and the rollout of a new website www.casipharmaceuticals.com.

Ken Ren, EntreMed's CEO, said, "Our operations and strategic focus have evolved and today have little resemblance to our legacy years. Our name change is another step towards our mission to build a new and leading biopharmaceutical company targeting global markets with a focus on China."